Arcus Biosciences, Inc.
They are a clinical-stage biopharmaceutical company focused on creating innovative cancer immunotherapies by leveraging underexploited biological opportunities.
$13.00 - $15.00
Citigroup, Goldman Sachs & Co., Leerink Partners
To view the prospectus for Arcus Biosciences, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277